Login / Signup

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.

Milton PackerJaved ButlerCordula ZellerStuart J PocockMartina BrueckmannJoao Pedro FerreiraGerasimos S FilippatosMuhammad Shariq UsmanFaiez ZannadStefan D Anker
Published in: Circulation (2023)
Keyphrases
  • placebo controlled
  • double blind
  • phase iii
  • open label
  • clinical trial
  • study protocol
  • replacement therapy